Sadia Ahmed
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sadia Ahmed has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
Amanda J Farrin
Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK
1 shared publicationAndrew Clegg
Academic Unit for Ageing and Stroke Research, Bradford Institute for Health Research, Bradford, UK
1 shared publicationAnne Forster
Academic Unit for Ageing and Stroke Research, Bradford Institute for Health Research, Bradford, UK
1 shared publicationAnne Heaven
Academic Unit for Ageing and Stroke Research, Bradford Institute for Health Research, Bradford, UK
1 shared publication- Arabella Baker
Centre of Evidence Based Dermatology, School of Medicine, University of Nottingham, Nottingham, UK
1 shared publication - Beth Stuart
Queen Mary University of London
1 shared publication
Latest Publications
- Open Access
- 14 October 2026
- Published by Elsevier in SSRN Electronic Journal
From Feasibility to Definitive Trials: Design and Protocol Modifications in Randomised Controlled Trials. A Scoping Review
BackgroundPilot and feasibility studies play an important role in developing and evaluating complex interventions prior to full-scale randomised controlled trials (RCTs). They allow researchers to assess trial processes, intervention delivery, acceptability, and implementation before definitive evaluation. Medical Research Council guidance recognises that interventions and procedures may need refinement during this process. Consequently, modifications to interventions and trial protocols may occur between pilot/feasibility studies and subsequent definitive RCTs. However, the nature, extent, and reporting of these modifications remain unclear. Inconsistent or poorly justified reporting may compromise interpretation of feasibility findings and weaken the rationale for progression to a trial. ObjectivesThis review aimed to identify and categorise modifications reported between pilot/feasibility studies and corresponding main RCTs, quantify their frequency, and determine whether modifications and their reasons were reported. MethodsA systematic search of CINAHL, Embase, MEDLINE, PsycINFO, and PubMed was conducted on 13 June 2025 to identify studies published from 2016 onwards. Eligible studies included completed or ongoing randomised controlled trials with a preceding published external pilot or feasibility study. Study selection was undertaken independently by two reviewers. Data on modifications were extracted, by PICOT domains, and classified as major or minor using a predefined framework. Data extraction was conducted by one reviewer and verified by a second. Formal risk-of-bias and certainty-of-evidence assessments were not undertaken, as the primary objective was to characterise and analyse modifications and reporting practices rather than evaluate intervention effects. ResultsA total of 3,361 records were identified, and 1,015 full-text articles were assessed for eligibility. Fifty-five pilot/feasibility–main trial studies were included. Modifications between pilot/feasibility and main trials were common, particularly for the population (73%) and intervention (64%). Changes were also observed in the comparator (42%), primary outcomes (29%), and timing of outcome assessment (16%). Modifications were classified as major or minor, with the majority classified as major across PICOT domains. Reporting varied across domains, with intervention changes most consistently documented. The review was limited by reliance on published reports and the absence of a validated framework for classifying modifications. These findings highlight a need for greater transparency in reporting modifications across trial components. ConclusionModifications between pilot/feasibility studies and related main RCTs are frequent and affect multiple trial components, particularly interventions and populations. However, reporting is inconsistent and lacks transparency. Poor reporting may make it difficult to judge whether feasibility findings adequately support the design and progression of a definitive trial. Improved and standardised reporting of modifications is needed to enhance the transparency, interpretability, reproducibility, and methodological rigour of trials transitioning from pilot/feasibility work to definitive evaluation. (PROSPERO: CRD420251020958)
- 14 October 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessFrom Feasibility to Definitive Trials: Design and Protocol Modifications in Randomised Controlled Trials. A Scoping Review
BackgroundPilot and feasibility studies play an important role in developing and evaluating complex interventions prior to full-scale randomised controlled trials (RCTs). They allow researchers to assess trial processes, intervention delivery, acceptability, and implementation before definitive evaluation. Medical Research Council guidance recognises that interventions and procedures may need refinement during this process. Consequently, modifications to interventions and trial protocols may occur between pilot/feasibility studies and subsequent definitive RCTs. However, the nature, extent, and reporting of these modifications remain unclear. Inconsistent or poorly justified reporting may compromise interpretation of feasibility findings and weaken the rationale for progression to a trial. ObjectivesThis review aimed to identify and categorise modifications reported between pilot/feasibility studies and corresponding main RCTs, quantify their frequency, and determine whether modifications and their reasons were reported. MethodsA systematic search of CINAHL, Embase, MEDLINE, PsycINFO, and PubMed was conducted on 13 June 2025 to identify studies published from 2016 onwards. Eligible studies included completed or ongoing randomised controlled trials with a preceding published external pilot or feasibility study. Study selection was undertaken independently by two reviewers. Data on modifications were extracted, by PICOT domains, and classified as major or minor using a predefined framework. Data extraction was conducted by one reviewer and verified by a second. Formal risk-of-bias and certainty-of-evidence assessments were not undertaken, as the primary objective was to characterise and analyse modifications and reporting practices rather than evaluate intervention effects. ResultsA total of 3,361 records were identified, and 1,015 full-text articles were assessed for eligibility. Fifty-five pilot/feasibility–main trial studies were included. Modifications between pilot/feasibility and main trials were common, particularly for the population (73%) and intervention (64%). Changes were also observed in the comparator (42%), primary outcomes (29%), and timing of outcome assessment (16%). Modifications were classified as major or minor, with the majority classified as major across PICOT domains. Reporting varied across domains, with intervention changes most consistently documented. The review was limited by reliance on published reports and the absence of a validated framework for classifying modifications. These findings highlight a need for greater transparency in reporting modifications across trial components. ConclusionModifications between pilot/feasibility studies and related main RCTs are frequent and affect multiple trial components, particularly interventions and populations. However, reporting is inconsistent and lacks transparency. Poor reporting may make it difficult to judge whether feasibility findings adequately support the design and progression of a definitive trial. Improved and standardised reporting of modifications is needed to enhance the transparency, interpretability, reproducibility, and methodological rigour of trials transitioning from pilot/feasibility work to definitive evaluation. (PROSPERO: CRD420251020958)
- Open Access
- 10 November 2025
- Published by Springer Nature in Trials
- Vol. 26 (1) , 1-5
Enhancing training in trials methodology research: insights from doctoral graduates
Training in trials methodology research is important for advancing clinical trials, ensuring the use of robust methods and addressing inefficiencies that can cause research waste. The Trials Methodology Research Partnership (TMRP) provides a specialised doctoral training programme to cultivate expertise in this distinct field. This article offers the perspectives of recent TMRP graduates, providing insights into skill development and professional growth delivered through structured training. These reflections highlight the value of comprehensive doctoral training in adequately equipping the next generation of trial methodologists to address evolving challenges and drive innovation in clinical trials. Recommendations for enhancing the training experience are provided with the aim to support the recruitment, development and retention of future methodologists.
- 10 November 2025
- Published by Springer Nature in Trials
- Vol. 26 (1) , 1-5
Open AccessEnhancing training in trials methodology research: insights from doctoral graduates
Training in trials methodology research is important for advancing clinical trials, ensuring the use of robust methods and addressing inefficiencies that can cause research waste. The Trials Methodology Research Partnership (TMRP) provides a specialised doctoral training programme to cultivate expertise in this distinct field. This article offers the perspectives of recent TMRP graduates, providing insights into skill development and professional growth delivered through structured training. These reflections highlight the value of comprehensive doctoral training in adequately equipping the next generation of trial methodologists to address evolving challenges and drive innovation in clinical trials. Recommendations for enhancing the training experience are provided with the aim to support the recruitment, development and retention of future methodologists.
- 16 April 2022
- Published by SAGE Publications in Research Methods in Medicine & Health Sciences
- Vol. 3 (3) , 66-73
A new opportunity for enhancing trial efficiency: Can we investigate intervention implementation processes within trials using SWAT (study within a trial) methodology?
Background: A study within a trial (SWAT) is a self-contained research study embedded within one or more host trials to evaluate or explore alternative ways of delivering or organising a particular trial process. There is limited evidence of SWATs evaluating trial processes other than recruitment and retention. Purpose: Embedding a SWAT into a host trial provides a potential method of evaluating an aspect of intervention implementation, such as engagement or compliance with the intervention. Research Design: This paper presents two case studies of SWATs which aim to test the use of video animations to improve intervention implementation, with particular focus on enhancing understanding, engagement and compliance. These are important aspects of intervention implementation as they are directly linked to intervention effectiveness and therefore, important to study. Results: In this paper, we present the potential benefits of conducting SWATs of intervention implementation processes as well as discussing the methodological considerations for embedding a SWAT of this nature within a host trial. Benefits include the opportunity to test minor refinements to intervention implementation within trials through robust randomised SWATs, and the possibility of increasing trial efficiency by maximising the quality or quantity of intervention implementation. Methodological considerations surrounding the design and conduct of the SWAT as well as statistical and health economics considerations are discussed in this paper. Conclusions: This paper presents a novel application of SWAT methodology in investigating intervention implementation processes within trial conduct.
- 16 April 2022
- Published by SAGE Publications in Research Methods in Medicine & Health Sciences
- Vol. 3 (3) , 66-73
A new opportunity for enhancing trial efficiency: Can we investigate intervention implementation processes within trials using SWAT (study within a trial) methodology?
Background: A study within a trial (SWAT) is a self-contained research study embedded within one or more host trials to evaluate or explore alternative ways of delivering or organising a particular trial process. There is limited evidence of SWATs evaluating trial processes other than recruitment and retention. Purpose: Embedding a SWAT into a host trial provides a potential method of evaluating an aspect of intervention implementation, such as engagement or compliance with the intervention. Research Design: This paper presents two case studies of SWATs which aim to test the use of video animations to improve intervention implementation, with particular focus on enhancing understanding, engagement and compliance. These are important aspects of intervention implementation as they are directly linked to intervention effectiveness and therefore, important to study. Results: In this paper, we present the potential benefits of conducting SWATs of intervention implementation processes as well as discussing the methodological considerations for embedding a SWAT of this nature within a host trial. Benefits include the opportunity to test minor refinements to intervention implementation within trials through robust randomised SWATs, and the possibility of increasing trial efficiency by maximising the quality or quantity of intervention implementation. Methodological considerations surrounding the design and conduct of the SWAT as well as statistical and health economics considerations are discussed in this paper. Conclusions: This paper presents a novel application of SWAT methodology in investigating intervention implementation processes within trial conduct.